Talphera (TLPH) Deferred Taxes (2010 - 2018)
Talphera's (TLPH) quarterly Deferred Taxes came in at $74000.0 in Q4 2018, down 45.59% year-on-year from $136000.0 in Q4 2017, and up 384.62% quarter-over-quarter from -$26000.0 in Q3 2018.
Talphera (TLPH) Deferred Taxes (2010 - 2018) Analysis & Trends
Talphera's Deferred Taxes history runs 9 years deep, the most recent figure standing at $74000.0 for Q4 2018.
- On a quarterly basis, Deferred Taxes fell 45.59% year-over-year to $74000.0 in Q4 2018; TTM through Dec 2018 was $113000.0, a 68.61% decrease from a year earlier, with the FY2019 full-year figure at -$352000.0, down 411.5% from the prior year.
- Deferred Taxes climbed to $74000.0 in Q4 2018 per TLPH's latest filing, from -$26000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $267000.0 in Q3 2017 and bottomed at -$196000.0 in Q4 2015.
- The 5-year median for Deferred Taxes is -$29000.0 (2014), against an average of -$1842.1.
- Across the five-year window, Deferred Taxes tumbled 1407.69% in 2015 and surged 613.46% in 2017, its largest moves.
- Year by year, Deferred Taxes stood at -$13000.0 in 2014, then tumbled by 1407.69% to -$196000.0 in 2015, then surged by 72.96% to -$53000.0 in 2016, then jumped by 356.6% to $136000.0 in 2017, then slumped by 45.59% to $74000.0 in 2018.
- Per Business Quant, the three latest TLPH Deferred Taxes figures stand at $74000.0 (Q4 2018), -$26000.0 (Q3 2018), and -$119000.0 (Q2 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 74,000.00 |
| Sep 30, 2018 | -26,000.00 |
| Jun 30, 2018 | -119,000.00 |
| Mar 31, 2018 | 184,000.00 |
| Dec 31, 2017 | 136,000.00 |
| Sep 30, 2017 | 267,000.00 |
| Mar 31, 2017 | -43,000.00 |
| Dec 31, 2016 | -53,000.00 |
| Sep 30, 2016 | -52,000.00 |
| Jun 30, 2016 | -49,000.00 |
| Mar 31, 2016 | -48,000.00 |
| Dec 31, 2015 | -196,000.00 |
| Sep 30, 2015 | -38,000.00 |
| Jun 30, 2015 | -37,000.00 |
| Mar 31, 2015 | -13,000.00 |
| Dec 31, 2014 | -13,000.00 |
| Sep 30, 2014 | 11,000.00 |
| Jun 30, 2014 | 9,000.00 |
| Mar 31, 2014 | -29,000.00 |
| Dec 31, 2013 | -29,000.00 |